Literature DB >> 23324219

The efficacy of L. (L.) chagasi excreted-secreted antigens (ESAs) for visceral leishmaniasis diagnosis is due to low levels of cross-reactivity.

Viviana Pinedo-Cancino1, Norival Kesper, Clara Lúcia Barbiéri, José Angelo Lauletta Lindoso, Eufrosina Setsu Umezawa.   

Abstract

The analysis of promastigote excreted-secreted antigen (ESA) reactivity with 53 visceral leishmaniasis (VL) cases showed that each sample reacted regardless of the antigen or the Leishmania species used in enzyme-linked immunosorbent assay (ELISA) displayed 100% positivity with the L. (L.) chagasi ESA-blot recognizing bands of molecular weight ranging from 26.5 to 31.5 kDa. The analysis of 160 non-visceral cases showed that 5% of the samples cross-reacted with the L. (L.) chagasi ESA-ELISA and 9.4% reacted with the ESA isolated from L. (L.) amazonensis and L. (V.) braziliensis, whereas a high cross-reaction ranging from 24.4% to 25% was observed with total crude promastigote antigens (PRO-ELISA). The ESA-blot of L. (L.) chagasi tested with non-visceral sera samples showed a cross-reaction with 8.8% of cases; most of these cases represented tegumentary leishmaniasis and only one acute chagasic case. These data lead us to recommend the use of ESA as an alternative antigen in VL diagnosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23324219      PMCID: PMC3592541          DOI: 10.4269/ajtmh.12-0587

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  32 in total

Review 1.  Diagnosis of visceral leishmaniasis: developments over the last decade.

Authors:  Gurumurthy Srividya; Arpita Kulshrestha; Ruchi Singh; Poonam Salotra
Journal:  Parasitol Res       Date:  2011-11-09       Impact factor: 2.289

2.  Enzyme-linked immunosorbent assay based on soluble promastigote antigen detects immunoglobulin M (IgM) and IgG antibodies in sera from cases of visceral and cutaneous leishmaniasis.

Authors:  Jeffrey R Ryan; Anthony M Smithyman; G-Halli Rajasekariah; Lisa Hochberg; John M Stiteler; Samuel K Martin
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

3.  Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiagnosis of congenital, acute, and chronic Chagas' disease.

Authors:  E S Umezawa; M S Nascimento; N Kesper; J R Coura; J Borges-Pereira; A C Junqueira; M E Camargo
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

4.  Secreted antigens of the amastigote and promastigote forms of Leishmania infantum inducing a humoral response in humans and dogs.

Authors:  P Cibrelus; E Précigout; D Sereno; B Carcy; J L Lemesre; A Gorenflot
Journal:  Parasite       Date:  1999-06       Impact factor: 3.000

5.  Optimisation of an ELISA for the serodiagnosis of visceral leishmaniasis using in vitro derived promastigote antigens.

Authors:  G H Rajasekariah; J R Ryan; S R Hillier; L P Yi; J M Stiteler; L Cui; A M Smithyman; S K Martin
Journal:  J Immunol Methods       Date:  2001-06-01       Impact factor: 2.303

6.  Enzyme-linked immunosorbent assay with Trypanosoma cruzi excreted-secreted antigens (TESA-ELISA) for serodiagnosis of acute and chronic Chagas' disease.

Authors:  E S Umezawa; M S Nascimento; A M Stolf
Journal:  Diagn Microbiol Infect Dis       Date:  2001-03       Impact factor: 2.803

7.  Leishmania donovani surface glycoconjugate GP36 is the major immunogen component of the fucose-mannose ligand (FML).

Authors:  C B Palatnik-de-Sousa; H S Dutra; R Borojevic
Journal:  Acta Trop       Date:  1993-03       Impact factor: 3.112

8.  rK39: a cloned antigen of Leishmania chagasi that predicts active visceral leishmaniasis.

Authors:  R Badaró; D Benson; M C Eulálio; M Freire; S Cunha; E M Netto; D Pedral-Sampaio; C Madureira; J M Burns; R L Houghton; J R David; S G Reed
Journal:  J Infect Dis       Date:  1996-03       Impact factor: 5.226

9.  Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.

Authors:  Zuleima C Caballero; Octavio E Sousa; Waldelania P Marques; Amadeo Saez-Alquezar; Eufrosina S Umezawa
Journal:  Clin Vaccine Immunol       Date:  2007-05-23

10.  Biosynthesis of galactofuranose in kinetoplastids: novel therapeutic targets for treating leishmaniasis and chagas' disease.

Authors:  Michelle Oppenheimer; Ana L Valenciano; Pablo Sobrado
Journal:  Enzyme Res       Date:  2011-05-25
View more
  6 in total

1.  Leptomonas seymouri and Crithidia fasciculata exoantigens can discriminate human cases of visceral leishmaniasis from American tegumentary leishmaniasis ones.

Authors:  Norival Kesper; Marta Maria G Teixeira; José Angelo L Lindoso; Clara Lúcia Barbieri; Eufrosina Setsu Umezawa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-04-03       Impact factor: 1.846

2.  Evaluation of recombinant K39 antigen and various promastigote antigens in sero-diagnosis of visceral leishmaniasis in Bangladesh.

Authors:  Sultana Shahana Banu; Be-Nazir Ahmed; Abul Khair Mohammad Shamsuzzaman; Rogan Lee
Journal:  Parasite Epidemiol Control       Date:  2016-07-30

3.  Systematic review on antigens for serodiagnosis of visceral leishmaniasis, with a focus on East Africa.

Authors:  Vera Kühne; Zahra Rezaei; Paul Pitzinger; Philippe Büscher
Journal:  PLoS Negl Trop Dis       Date:  2019-08-15

4.  Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.

Authors:  Wafa Markikou-Ouni; Sima Drini; Narges Bahi-Jaber; Mehdi Chenik; Amel Meddeb-Garnaoui
Journal:  PLoS One       Date:  2015-11-18       Impact factor: 3.240

Review 5.  Place of Serology in the Diagnosis of Zoonotic Leishmaniases With a Focus on Visceral Leishmaniasis Due to Leishmania infantum.

Authors:  Maude F Lévêque; Laurence Lachaud; Loïc Simon; Emilie Battery; Pierre Marty; Christelle Pomares
Journal:  Front Cell Infect Microbiol       Date:  2020-02-25       Impact factor: 5.293

6.  Field validation of a Leishmania (Leishmania) mexicana exo-antigens ELISA for diagnosing tegumentary leishmaniasis in regions of Leishmania (Viannia) predominance.

Authors:  Killarney Ataide Soares; Ada Amália Ayala Urdapilleta; Gilcilene Maria dos Santos; Andréa Lisboa Carneiro; Ciro Martins Gomes; Ana Maria Roselino; Raimunda Nonata Ribeiro Sampaio
Journal:  Braz J Infect Dis       Date:  2015-05-15       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.